Gene network analysis of small molecules with autoimmune disease associated genes predicts a novel strategy for drug efficacy

Autoimmunity Reviews

Volumn 12, Issue 4, 2013, Pages 510-522

  Maiti, Amit K ^a   Nath, Swapan K ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; AUTOIMMUNE DISEASE; GENE INTERACTION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; PHARMACOGENETICS; PHENOTYPE; REVIEW; AUTOIMMUNITY; DRUG EFFECT; EPISTASIS; GENETICS; HUMAN;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; EPISTASIS, GENETIC; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PHARMACOGENETICS; PHENOTYPE;

MLCS; MLOWN;

EID: 84880946386     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.09.001     Document Type: Review

References (134)

1. Cooper G.S., Bynum M.L., Somers E.C. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 2009, 33(3-4):197-207.
2. Lettre G., Rioux J.D. Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet 2008, 17(R2):R116-R121.
3. Ramos P.S., Criswell L.A., Moser K.L., Comeau M.E., Williams A.H., Pajewski N.M., et al. A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap. PLoS Genet 2011, 7(12):e1002406.
4. Cotsapas C., Voight B.F., Rossin E., Lage K., Neale B.M., Wallace C., et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet 2011, 7(8):e1002254.
5. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357(10):977-986.
6. Graham R.R., Cotsapas C., Davies L., Hackett R., Lessard C.J., Leon J.M., et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 2008, 40(9):1059-1061.
7. Plenge R.M., Cotsapas C., Davies L., Price A.L., de Bakker P.I., Maller J., et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 2007, 39(12):1477-1482.
8. Musone S.L., Taylor K.E., Lu T.T., Nititham J., Ferreira R.C., Ortmann W., et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet 2008, 40(9):1062-1064.
9. Begovich A.B., Caillier S.J., Alexander H.C., Penko J.M., Hauser S.L., Barcellos L.F., et al. The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. Am J Hum Genet 2005, 76(1):184-187.
10. Plenge R.M., Padyukov L., Remmers E.F., Purcell S., Lee A.T., Karlson E.W., et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005, 77(6):1044-1060.
11. Lee Y.H., Rho Y.H., Choi S.J., Ji J.D., Song G.G., Nath S.K., et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases-a meta-analysis. Rheumatology (Oxford) 2007, 46(1):49-56.
12. Graham R.R., Kozyrev S.V., Baechler E.C., Reddy M.V., Plenge R.M., Bauer J.W., et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006, 38(5):550-555.
13. Santana-de Anda K., Gomez-Martin D., Diaz-Zamudio M., Alcocer-Varela J. Interferon regulatory factors: beyond the antiviral response and their link to the development of autoimmune pathology. Autoimmun Rev 2011, 11(2):98-103.
14. Todd J.A., Walker N.M., Cooper J.D., Smyth D.J., Downes K., Plagnol V., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007, 39(7):857-864.
15. Smyth D.J., Plagnol V., Walker N.M., Cooper J.D., Downes K., Yang J.H., et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008, 359(26):2767-2777.
16. Maiti A.K., Kim-Howard X., Viswanathan P., Guillen L., Qian X., Rojas-Villarraga A., et al. Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases. Rheumatology (Oxford) 2010, 49(7):1239-1244.
17. Fierabracci A., Milillo A., Locatelli F., Fruci D. The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: Insights from genomic-wide association studies. Autoimmun Rev 2012, 12(2):281-288. (this volume).
18. Kuhn M., Szklarczyk D., Franceschini A., von Mering C., Jensen L.J., Bork P. STITCH 3: zooming in on protein-chemical interactions. Nucleic Acids Res 2012, 40(Database issue):D876-D880.
19. Springer T.A. Folding of the N-terminal, ligand-binding region of integrin alpha-subunits into a beta-propeller domain. Proc Natl Acad Sci U S A 1997, 94(1):65-72.
20. Corbi A.L., Kishimoto T.K., Miller L.J., Springer T.A. The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) alpha subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B. J Biol Chem 1988, 263(25):12403-12411.
21. Nath S.K., Han S., Kim-Howard X., Kelly J.A., Viswanathan P., Gilkeson G.S., et al. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat Genet 2008, 40(2):152-154.
22. Kim-Howard X., Maiti A.K., Anaya J.M., Bruner G.R., Brown E., Merrill J.T., et al. ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash, and immunologic manifestations in lupus patients with European ancestry. Ann Rheum Dis 2009.
23. Zhernakova A., van Diemen C.C., Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 2009, 10(1):43-55.
24. Harley I.T., Kaufman K.M., Langefeld C.D., Harley J.B., Kelly J.A. Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat Rev Genet 2009, 10(5):285-290.
25. Gateva V., Sandling J.K., Hom G., Taylor K.E., Chung S.A., Sun X., et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009, 41(11):1228-1233.
26. Yang W., Shen N., Ye D.Q., Liu Q., Zhang Y., Qian X.X., et al. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet 2010, 6(2):e1000841.
27. Harley J.B., Alarcon-Riquelme M.E., Criswell L.A., Jacob C.O., Kimberly R.P., Moser K.L., et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008, 40(2):204-210.
28. Kim K., Cho S.K., Sestak A., Namjou B., Kang C., Bae S.C. Interferon-gamma gene polymorphisms associated with susceptibility to systemic lupus erythematosus. Ann Rheum Dis 2010, 69(6):1247-1250.
29. Noomen C.G., Hommes D.W., Fidder H.H. Update on genetics in inflammatory disease. Best Pract Res Clin Gastroenterol 2009, 23(2):233-243.
30. Dai R., Ahmed S.A. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res 2011, 157(4):163-179.
31. Bang-Berthelsen C.H., Pedersen L., Floyel T., Hagedorn P.H., Gylvin T., Pociot F. Independent component and pathway-based analysis of miRNA-regulated gene expression in a model of type 1 diabetes. BMC Genomics 2011, 12:97.
32. Lundstrom K. Micro-RNA in Disease and Gene Therapy. Curr Drug Discov Technol 2011, 8(2):76-86.
33. Raychaudhuri S., Remmers E.F., Lee A.T., Hackett R., Guiducci C., Burtt N.P., et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008, 40(10):1216-1223.
34. Maiti A.K., Kim-Howard X., Viswanathan P., Guillen L., Rojas-Villarraga A., Deshmukh H., et al. Confirmation of an association between rs6822844 at the Il2-Il21 region and multiple autoimmune diseases: evidence of a general susceptibility locus. Arthritis Rheum 2010, 62(2):323-329.
35. Lu R., Vidal G.S., Kelly J.A., Delgado-Vega A.M., Howard X.K., Macwana S.R., et al. Genetic associations of LYN with systemic lupus erythematosus. Genes Immun 2009, 10(5):397-403.
36. Stahl E.A., Raychaudhuri S., Remmers E.F., Xie G., Eyre S., Thomson B.P., et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010, 42(6):508-514.
37. Franke A., Fischer A., Nothnagel M., Becker C., Grabe N., Till A., et al. Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2. Gastroenterology 2008, 135(4):1207-1215.
38. Dalal S.R., Kwon J.H. The Role of MicroRNA in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y) 2010, 6(11):714-722.
39. Criswell L.A. Gene discovery in rheumatoid arthritis highlights the CD40/NF-kappaB signaling pathway in disease pathogenesis. Immunol Rev 2010, 233(1):55-61.
40. Zhernakova A., Stahl E.A., Trynka G., Raychaudhuri S., Festen E.A., Franke L., et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 2011, 7(2):e1002004.
41. Hoffjan S., Akkad D.A. The genetics of multiple sclerosis: an update 2010. Mol Cell Probes 2010, 24(5):237-243.
42. Kuijpers T.W., Van Lier R.A., Hamann D., de Boer M., Thung L.Y., Weening R.S., et al. Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins. J Clin Invest 1997, 100(7):1725-1733.
43. Gregersen P.K., Amos C.I., Lee A.T., Lu Y., Remmers E.F., Kastner D.L., et al. REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet 2009, 41(7):820-823.
44. Costenbader K.H., Gay S., Alarcon-Riquelme M.E., Iaccarino L., Doria A. Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?. Autoimmun Rev 2012, 11(8):604-609.
45. Pender M.P. CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis. Autoimmune Dis 2012, 2012:189096.
46. Singh R.P., Waldron R.T., Hahn B.H. Genes, tolerance and systemic autoimmunity. Autoimmun Rev 2012, 11(9):664-669.
47. Kawai K., Tsuno N.H., Matsuhashi M., Kitayama J., Osada T., Yamada J., et al. CD11b-mediated migratory property of peripheral blood B cells. J Allergy Clin Immunol 2005, 116(1):192-197.
48. Arnold L.W., Pennell C.A., McCray S.K., Clarke S.H. Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J Exp Med 1994, 179(5):1585-1595.
49. Cutolo M., Sulli A., Capellino S., Villaggio B., Montagna P., Seriolo B., et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004, 13(9):635-638.
50. Walker S.E. Estrogen and autoimmune disease. Clin Rev Allergy Immunol 2011, 40(1):60-65.
51. Wada T., Furuichi K., Sakai N., Iwata Y., Yoshimoto K., Shimizu M., et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 2000, 58(4):1492-1499.
52. Ingegnoli F., Favalli E.G., Meroni P.L. Does polymorphysm of genes coding for pro-inflammatory mediators predict the clinical response to tnf alpha blocking agents? A review analysis of the literature. Autoimmun Rev 2011, 10(8):460-463.
53. Zakka L.R., Reche P., Ahmed A.R. Role of MHC Class II genes in the pathogenesis of pemphigoid. Autoimmun Rev 2011, 11(1):40-47.
54. Touitou I. New genetic interpretation of old diseases. Autoimmun Rev 2012, (Epub ahead of print).
55. Hom G., Graham R.R., Modrek B., Taylor K.E., Ortmann W., Garnier S., et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008, 358(9):900-909.
56. Shoenfeld Y. The future of autoimmunity. Clin Rev Allergy Immunol 2012, 42(2):113-120.
57. Lu R., Vidal G.S., Kelly J.A., Delgado-Vega A.M., Howard X.K., Macwana S.R., et al. Genetic associations of LYN with systemic lupus erythematosus. Genes Immun 2009, 10(5):393-403.
58. Kozyrev S.V., Abelson A.K., Wojcik J., Zaghlool A., Linga Reddy M.P., Sanchez E., et al. Corrigendum: Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 2008, 40(4):484.
59. Lofgren S.E., Frostegard J., Truedsson L., Pons-Estel B.A., D'Alfonso S., Witte T., et al. Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene. Genes Immun 2012, 13(3):268-274.
60. Jacob C.O., Reiff A., Armstrong D.L., Myones B.L., Silverman E., Klein-Gitelman M., et al. Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform. Arthritis Rheum 2007, 56(12):4164-4173.
61. Sawalha A.H., Webb R., Han S., Kelly J.A., Kaufman K.M., Kimberly R.P., et al. Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS One 2008, 3(3):e1727.
62. Smyth D.J., Howson J.M., Payne F., Maier L.M., Bailey R., Holland K., et al. Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases. BMC Med Genet 2006, 7:20.
63. Graham D.S., Akil M., Vyse T.J. Association of polymorphisms across the tyrosine kinase gene, TYK2 in UK SLE families. Rheumatology (Oxford) 2007, 46(6):927-930.
64. Siminovitch K.A. PTPN22 and autoimmune disease. Nat Genet 2004, 36(12):1248-1249.
65. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004, 36(4):337-338.
66. Alarcon G.S., McGwin G., Petri M., Ramsey-Goldman R., Fessler B.J., Vila L.M., et al. Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort. PLoS Med 2006, 3(10):e396.
67. Cooper J.D., Smyth D.J., Smiles A.M., Plagnol V., Walker N.M., Allen J.E., et al. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet 2008, 40(12):1399-1401.
68. Jacob C.O., Zhu J., Armstrong D.L., Yan M., Han J., Zhou X.J., et al. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A 2009, 106(15):6256-6261.
69. Han J.W., Zheng H.F., Cui Y., Sun L.D., Ye D.Q., Hu Z., et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009, 41(11):1234-1237.
70. Oishi T., Iida A., Otsubo S., Kamatani Y., Usami M., Takei T., et al. A functional SNP in the NKX2.5-binding site of ITPR3 promoter is associated with susceptibility to systemic lupus erythematosus in Japanese population. J Hum Genet 2008, 53(2):151-162.
71. Nusinow S.R., Zuraw B.L., Curd J.G. The hereditary and acquired deficiencies of complement. Med Clin North Am 1985, 69(3):487-504.
72. Budarf M.L., Goyette P., Boucher G., Lian J., Graham R.R., Claudio J.O., et al. A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles. Genes Immun 2011, 12(1):51-58.
73. Vazgiourakis V.M., Zervou M.I., Choulaki C., Bertsias G., Melissourgaki M., Yilmaz N., et al. A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis. Ann Rheum Dis 2011, 70(12):2184-2190.
74. Hong C.H., Lee J.S., Lee H.S., Bae S.C., Yoo D.H. The association between fcgammaRIIIB polymorphisms and systemic lupus erythematosus in Korea. Lupus 2005, 14(5):346-350.
75. Prokunina L., Castillejo-Lopez C., Oberg F., Gunnarsson I., Berg L., Magnusson V., et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002, 32(4):666-669.
76. Reveille J.D., Moulds J.M., Ahn C., Friedman A.W., Baethge B., Roseman J., et al. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 1998, 41(7):1161-1172.
77. Sadovnick A.D. Genetic background of multiple sclerosis. Autoimmun Rev 2012, 11(3):163-166.
78. Moser K.L., Neas B.R., Salmon J.E., Yu H., Gray-McGuire C., Asundi N., et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci U S A 1998, 95(25):14869-14874.
79. Raychaudhuri S., Thomson B.P., Remmers E.F., Eyre S., Hinks A., Guiducci C., et al. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet 2009, 41(12):1313-1318.
80. Furnrohr B.G., Wach S., Kelly J.A., Haslbeck M., Weber C.K., Stach C.M., et al. Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus. Ann Rheum Dis 2010, 69(11):1983-1989.
81. Al-Mayouf S.M., Sunker A., Abdwani R., Abrawi S.A., Almurshedi F., Alhashmi N., et al. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat Genet 2011, 43(12):1186-1188.
82. Yasutomo K., Horiuchi T., Kagami S., Tsukamoto H., Hashimura C., Urushihara M., et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 2001, 28(4):313-314.
83. Kim K., Brown E.E., Choi C.B., Alarcon-Riquelme M.E., Kelly J.A., Glenn S.B., et al. Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries. Ann Rheum Dis 2012, (Epub ahead of print).
84. Hakonarson H., Grant S.F., Bradfield J.P., Marchand L., Kim C.E., Glessner J.T., et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007, 448(7153):591-594.
85. Awata T., Kawasaki E., Tanaka S., Ikegami H., Maruyama T., Shimada A., et al. Association of type 1 diabetes with two Loci on 12q13 and 16p13 and the influence coexisting thyroid autoimmunity in Japanese. J Clin Endocrinol Metab 2009, 94(1):231-235.
86. Cooper J.D., Walker N.M., Healy B.C., Smyth D.J., Downes K., Todd J.A. Analysis of 55 autoimmune disease and type II diabetes loci: further confirmation of chromosomes 4q27, 12q13.2 and 12q24.13 as type I diabetes loci, and support for a new locus, 12q13.3-q14.1. Genes Immun 2009, 10(Suppl. 1):S95-S120.
87. Barratt B.J., Payne F., Lowe C.E., Hermann R., Healy B.C., Harold D., et al. Remapping the insulin gene/IDDM2 locus in type 1 diabetes. Diabetes 2004, 53(7):1884-1889.
88. Espino-Paisan L., de la Calle H., Fernandez-Arquero M., Figueredo M.A., de la Concha E.G., Urcelay E., et al. A polymorphism in PTPN2 gene is associated with an earlier onset of type 1 diabetes. Immunogenetics 2011, 63(4):255-258.
89. Freudenberg J., Lee H.S., Han B.G., Shin H.D., Kang Y.M., Sung Y.K., et al. Genome-wide association study of rheumatoid arthritis in Koreans: population-specific loci as well as overlap with European susceptibility loci. Arthritis Rheum 2011, 63(4):884-893.
90. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423(6939):506-511.
91. Franke A., McGovern D.P., Barrett J.C., Wang K., Radford-Smith G.L., Ahmad T., et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010, 42(12):1118-1125.
92. Perdigones N., Vigo A.G., Lamas J.R., Martinez A., Balsa A., Pascual-Salcedo D., et al. Evidence of epistasis between TNFRSF14 and TNFRSF6B polymorphisms in patients with rheumatoid arthritis. Arthritis Rheum 2010, 62(3):705-710.
93. Wagner J., Sim W.H., Ellis J.A., Ong E.K., Catto-Smith A.G., Cameron D.J., et al. Interaction of Crohn's disease susceptibility genes in an Australian paediatric cohort. PLoS One 2010, 5(11):e15376.
94. Ho P., Bruce I.N., Silman A., Symmons D., Newman B., Young H., et al. Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritis. Arthritis Rheum 2005, 52(11):3596-3602.
95. McGovern D.P., Hysi P., Ahmad T., van Heel D.A., Moffatt M.F., Carey A., et al. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet 2005, 14(10):1245-1250.
96. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411(6837):599-603.
97. Orozco G., Gonzalez-Gay M.A., Paco L., Lopez-Nevot M.A., Guzman M., Pascual-Salcedo D., et al. Interleukin 12 (IL12B) and interleukin 12 receptor (IL12RB1) gene polymorphisms in rheumatoid arthritis. Hum Immunol 2005, 66(6):710-715.
98. Cargill M., Schrodi S.J., Chang M., Garcia V.E., Brandon R., Callis K.P., et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007, 80(2):273-290.
99. Plenge R.M., Seielstad M., Padyukov L., Lee A.T., Remmers E.F., Ding B., et al. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 2007, 357(12):1199-1209.
100. Hunt K.A., Zhernakova A., Turner G., Heap G.A., Franke L., Bruinenberg M., et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 2008, 40(4):395-402.
101. Coenen M.J., Trynka G., Heskamp S., Franke B., van Diemen C.C., Smolonska J., et al. Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum Mol Genet 2009, 18(21):4195-4203.
102. Suzuki A., Yamada R., Kochi Y., Sawada T., Okada Y., Matsuda K., et al. Functional SNPs in CD244 increase the risk of rheumatoid arthritis in a Japanese population. Nat Genet 2008, 40(10):1224-1229.
103. Mattey D.L., Nixon N., Dawes P.T., Kerr J. Association of polymorphism in the transforming growth factor {beta}1 gene with disease outcome and mortality in rheumatoid arthritis. Ann Rheum Dis 2005, 64(8):1190-1194.
104. Barton A., Eyre S., Ke X., Hinks A., Bowes J., Flynn E., et al. Identification of AF4/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes. Hum Mol Genet 2009, 18(13):2518-2522.
105. Okada Y., Terao C., Ikari K., Kochi Y., Ohmura K., Suzuki A., et al. Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population. Nat Genet 2012, 44(5):511-516.
106. Docampo E., Rabionet R., Riveira-Munoz E., Escaramis G., Julia A., Marsal S., et al. Deletion of the late cornified envelope genes, LCE3C and LCE3B, is associated with rheumatoid arthritis. Arthritis Rheum 2010, 62(5):1246-1251.
107. Rivas M.A., Beaudoin M., Gardet A., Stevens C., Sharma Y., Zhang C.K., et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 2011, 43(11):1066-1073.
108. Anderson C.A., Massey D.C., Barrett J.C., Prescott N.J., Tremelling M., Fisher S.A., et al. Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 2009, 136(2):523-529. [e523].
109. Amre D.K., Mack D.R., Morgan K., Israel D., Deslandres C., Seidman E.G., et al. Susceptibility loci reported in genome-wide association studies are associated with Crohn's disease in Canadian children. Aliment Pharmacol Ther 2010, 31(11):1186-1191.
110. Hampe J., Franke A., Rosenstiel P., Till A., Teuber M., Huse K., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007, 39(2):207-211.
111. Wang K., Zhang H., Kugathasan S., Annese V., Bradfield J.P., Russell R.K., et al. Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. Am J Hum Genet 2009, 84(3):399-405.
112. Danoy P., Pryce K., Hadler J., Bradbury L.A., Farrar C., Pointon J., et al. Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease. PLoS Genet 2010, 6(12):e1001195.
113. Hauser F., Deyle C., Berard D., Neukirch C., Glowacki C., Bickmann J.K., et al. Macrophage-stimulating protein polymorphism rs3197999 is associated with a gain of function: implications for inflammatory bowel disease. Genes Immun 2012, 13(4):321-327.
114. Barrett J.C., Hansoul S., Nicolae D.L., Cho J.H., Duerr R.H., Rioux J.D., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40(8):955-962.
115. van der Heide F., Nolte I.M., Kleibeuker J.H., Wijmenga C., Dijkstra G., Weersma R.K. Differences in genetic background between active smokers, passive smokers, and non-smokers with Crohn's disease. Am J Gastroenterol 2010, 105(5):1165-1172.
116. Aithal G.P., Craggs A., Day C.P., Welfare M., Daly A.K., Mansfield J.C., et al. Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflamatory bowel disease. Dig Dis Sci 2001, 46(7):1520-1525.
117. Koutroubakis I.E., Theodoropoulou A., Xidakis C., Sfiridaki A., Notas G., Kolios G., et al. Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2004, 16(11):1147-1152.
118. Weersma R.K., Stokkers P.C., Cleynen I., Wolfkamp S.C., Henckaerts L., Schreiber S., et al. Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort. Am J Gastroenterol 2009, 104(3):630-638.
119. Kugathasan S., Baldassano R.N., Bradfield J.P., Sleiman P.M., Imielinski M., Guthery S.L., et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 2008, 40(10):1211-1215.
120. McGovern D.P., Gardet A., Torkvist L., Goyette P., Essers J., Taylor K.D., et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet 2010, 42(4):332-337.
121. Massey D.C., Parkes M. Genome-wide association scanning highlights two autophagy genes, ATG16L1 and IRGM, as being significantly associated with Crohn's disease. Autophagy 2007, 3(6):649-651.
122. Leung E., Hong J., Fraser A.G., Merriman T.R., Vishnu P., Krissansen G.W. Polymorphisms in the organic cation transporter genes SLC22A4 and SLC22A5 and Crohn's disease in a New Zealand Caucasian cohort. Immunol Cell Biol 2006, 84(2):233-236.
123. Yamazaki K., McGovern D., Ragoussis J., Paolucci M., Butler H., Jewell D., et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 2005, 14(22):3499-3506.
124. Weber F., Fontaine B., Cournu-Rebeix I., Kroner A., Knop M., Lutz S., et al. IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes Immun 2008, 9(3):259-263.
125. Esposito L. IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes Immun 2010, 11(5):397-405.
126. Booth D.R., Arthur A.T., Teutsch S.M., Bye C., Rubio J., Armati P.J., et al. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis. J Mol Med 2005, 83(10):822-830.
127. Guerini F.R., Cagliani R., Forni D., Agliardi C., Caputo D., Cassinotti A., et al. A functional variant in ERAP1 predisposes to multiple sclerosis. PLoS One 2012, 7(1):e29931.
128. Arnaud-Lopez L., Usala G., Ceresini G., Mitchell B.D., Pilia M.G., Piras M.G., et al. Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. Am J Hum Genet 2008, 82(6):1270-1280.
129. Capon F., Bijlmakers M.J., Wolf N., Quaranta M., Huffmeier U., Allen M., et al. Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene. Hum Mol Genet 2008, 17(13):1938-1945.
130. Hollox E.J. Copy number variation of beta-defensins and relevance to disease. Cytogenet Genome Res 2008, 123(1-4):148-155.
131. van Heel D.A., Franke L., Hunt K.A., Gwilliam R., Zhernakova A., Inouye M., et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007, 39(7):827-829.
132. Fisher S.A., Tremelling M., Anderson C.A., Gwilliam R., Bumpstead S., Prescott N.J., et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 2008, 40(6):710-712.
133. De Jager P.L., Chibnik L.B., Cui J., Reischl J., Lehr S., Simon K.C., et al. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol 2009, 8(12):1111-1119.
134. Narumi Y., Isomoto H., Shiota M., Sato K., Kondo S., Machida H., et al. Polymorphisms of PTPN11 coding SHP-2 as biomarkers for ulcerative colitis susceptibility in the Japanese population. J Clin Immunol 2009, 29(3):303-310.